tirzepatide 199 a month Compounded from $149/Month: CoraDoc's Provider-Supervised Program Explained | CoraDoc™ 🚨 NOW OFFERING SKINNY SHOTS

This medication is a compounded product

Average body weight reduction: 5 mg weekly: 16.0% reduction (approximately 35 pounds for a 220-pound person) 10 mg weekly: 21.4% reduction (approximately 47 pounds) 15 mg weekly: 22.5% reduction (approximately 50 pounds) Placebo: 2.4% reduction Percentage of participants achieving clinically significant weight loss: 5% or more weight loss: 85% at 5 mg, 89% at 10 mg, 91% at 15 mg 10% or more weight loss: 69% at 5 mg, 78% at 10 mg, 84% at 15 mg 20% or more weight loss: 32% at 5 mg, 49% at 10 mg, 57% at 15 mg Look at those numbers carefully

Clinical trial protocols and obesity-medicine guidance generally evaluate GLP-1 medications alongside nutrition, physical activity, and ongoing medical supervision rather than as standalone interventions

Energy use: The glucagon target is tied to how the body burns stored energy, which is a separate research angle that two-target peptides do not cover